Abstract
Based on a computational model for 5-HT(1A)R-ligand interaction and QSAR studies, we have designed and synthesized a new series of arylpiperazines 2-8 which exhibit high 5-HT(1A)R affinity and selectivity over alpha(1)-adrenergic receptors. Among them, compound CSP-2503 (4) has been pharmacologically characterized as a 5-HT(1A)R agonist at somatodendritic and postsynaptic sites, endowed with anxiolytic properties.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Sequence
-
Animals
-
Anti-Anxiety Agents / chemical synthesis
-
Anti-Anxiety Agents / pharmacology
-
Benzene Derivatives / chemistry
-
Benzene Derivatives / metabolism
-
Benzene Derivatives / pharmacology
-
Body Temperature / drug effects
-
Computer Simulation
-
Dose-Response Relationship, Drug
-
Drug Design
-
HeLa Cells
-
Humans
-
Mice
-
Models, Molecular
-
Piperazines / chemical synthesis*
-
Piperazines / chemistry
-
Piperazines / metabolism
-
Piperazines / pharmacology*
-
Pyrazines / chemical synthesis
-
Pyrazines / chemistry
-
Pyrazines / pharmacology
-
Quantitative Structure-Activity Relationship
-
Receptors, Adrenergic, alpha-1 / metabolism
-
Receptors, Serotonin, 5-HT1 / drug effects*
-
Receptors, Serotonin, 5-HT1 / metabolism
-
Serotonin Receptor Agonists / chemical synthesis*
-
Serotonin Receptor Agonists / chemistry
-
Serotonin Receptor Agonists / metabolism
-
Serotonin Receptor Agonists / pharmacology*
-
Synaptic Transmission / drug effects
Substances
-
2-((4-(naphth-1-yl)piperazin-1-yl)methyl)-1,4-dioxoperhydropyrrolo(1,2-a)pyrazine
-
Anti-Anxiety Agents
-
Benzene Derivatives
-
Piperazines
-
Pyrazines
-
Receptors, Adrenergic, alpha-1
-
Receptors, Serotonin, 5-HT1
-
Serotonin Receptor Agonists